| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ardelyx, Inc. (ARDX) has 9 insiders with recent SEC Form 4 filings, including 1 buy and 13 sells. ARDX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 3.30M | $21.04M | - | |
| CEO | 1.74M | $11.09M | -41,666 | |
| Other | 409.9K | $2.61M | - | |
| CFO | 409.1K | $2.61M | - | |
| Other | 339.5K | $2.16M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 17, 2020 | Raab Michael56 | President &CEO | Sell | 20,428 | $7.02 | $143,325.28 | -6.4% | |
| Mar 2, 2020 | Raab Michael56 | President &CEO | Sale+OE | 31,551 | $7.01 | $221,145.03 | -9.0% | |
| Feb 5, 2020 | Raab Michael56 | President &CEO | Sale+OE | 25,000 | $7.32 | $182,927.50 | -10.8% | |
| Dec 30, 2019 | Grammer Elizabeth A58 | EVP, General Counsel | Buy | 66 | $7.51 | $495.92 | +3.3% | |
| Dec 3, 2019 | Grammer Elizabeth A58 | EVP, General Counsel | Sale+OE | 5,000 | $8.00 | $40,000.00 | -4.1% | |
| Nov 19, 2019 | Grammer Elizabeth A58 | EVP, General Counsel | Sale+OE | 5,000 | $7.00 | $35,000.00 | -4.1% | |
| Oct 7, 2019 | Kaufmann Mark | Chief Financial Officer | Sale+OE | 20,000 | $4.56 | $91,190.00 | -12.4% | |
| Aug 22, 2019 | Grammer Elizabeth A58 | EVP, General Counsel | Sell | 5,000 | $3.50 | $17,500.00 | -2.1% | |
| Aug 19, 2019 | Grammer Elizabeth A58 | EVP, General Counsel | Sell | 5,874 | $0.00 | - | -4.6% | |
| Jun 4, 2019 | Kaufmann Mark | Chief Financial Officer | Sell | 3,357 | $2.55 | $8,550.95 | -2.4% |